Journal
JOURNAL OF CONTROLLED RELEASE
Volume 273, Issue -, Pages 51-67Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2018.01.021
Keywords
Stimuli-responsive, nanoparticles; Bone therapeutics delivery; Controlled release
Funding
- European Research Council [ERC-2014-ADG-669858]
- Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/119983/2016]
Ask authors/readers for more resources
The development of stimuli-responsive nanomedicines with tunable cargo release is gathering an increased applicability in bone regeneration and precision biomedicine. Yet, the formulation of nanocarriers that explore skeletal-specific stimuli remains remarkably challenging to materialize due to several endogenous and disease-specific barriers that must be considered during particle design stages. Such anatomo-physiological constrains ultimately hinder nanocarriers bioavailability in target bone tissues and impact the overall therapeutic outcome. This review aims to showcase and critically discuss the hurdles encountered upon responsive nanocarriers delivery in the context of skeletal diseases or tissue regeneration scenarios. Such focus is complemented with an in-depth and up-to-date analysis of advances in the development of stimuli-responsive, bone-focused delivery systems. In a holistic perspective, a deeper knowledge of human osteology combined with advances in materials functionalization via simple precision-chemistry is envisioned to incite the manufacture of stimuli-triggered nanomedicines with more realistic potential for clinical translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available